Debiopharm Innovation Fund logo

Debiopharm Innovation Fund

Europe, Vaud, Switzerland, Lausanne

Description

Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.

Investor Profile

Debiopharm Innovation Fund has made 29 investments, with 2 in the past 12 months and 52% as lead.

Stage Focus

  • Series A (41%)
  • Seed (17%)
  • Series C (10%)
  • Series B (10%)
  • Pre Seed (7%)
  • Series Unknown (7%)
  • Post Ipo Equity (3%)
  • Series E (3%)

Country Focus

  • United States (34%)
  • Switzerland (24%)
  • France (10%)
  • Germany (7%)
  • United Kingdom (7%)
  • Spain (3%)
  • Canada (3%)
  • Belgium (3%)
  • Finland (3%)
  • Israel (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • Life Science
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Debiopharm Innovation Fund frequently co-invest with?

GH
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Vertex Ventures Israel
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Criteria Venture Tech
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Cerner Capital
North America, Georgia, United States, Atlanta
Co-Investments: 2
Tesi
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 3
Philips Health Technology Ventures
Europe, Drenthe, The Netherlands, Nieuw-amsterdam
Co-Investments: 2
LRVHealth
North America, Massachusetts, United States, Boston
Co-Investments: 2
Section 32
North America, California, United States, San Diego
Co-Investments: 2
HLM Venture Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Grove Ventures
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2

Which angels does Debiopharm Innovation Fund often collaborate with?

YS
North America, California, United States, San Francisco
Shared Deals: 1
RG
North America, Massachusetts, United States, Boston
Shared Deals: 1
MS
Europe, Berlin, Germany, Berlin
Shared Deals: 1
DF
North America, California, United States, San Francisco
Shared Deals: 1
MH
North America, Florida, United States, Miami Beach
Shared Deals: 2

What are some of recent deals done by Debiopharm Innovation Fund?

MedaSystems

Menlo Park, California, United States

Expanded Access software for biopharmaceuticals

BiopharmaPharmaceuticalSoftware
SeedMar 5, 2025
StratifAI

Dresden, Sachsen, Germany

Building the next generation of biomarkers for precision oncology

Artificial Intelligence (AI)Health CareOncology
Pre SeedSep 2, 2024
Amount Raised: $1,660,275
MedaSystems

Menlo Park, California, United States

Expanded Access software for biopharmaceuticals

BiopharmaPharmaceuticalSoftware
SeedJan 9, 2024
OmicsChart

Cardiff, Cardiff, United Kingdom

Patient-centric cancer data and analytics platform for translational cancer biologists

BioinformaticsBiopharmaGeneticsLife ScienceOncologySoftware
Pre SeedOct 9, 2023
Amount Raised: $317,361
Altis Labs

Toronto, Ontario, Canada

Altis helps biopharma run faster and more successful clinical trials using AI models trained on the world's largest cancer imaging database.

BioinformaticsBiopharmaClinical TrialsCloud ComputingEnterprise SoftwareHealth CareHealth DiagnosticsLife ScienceMachine LearningPharmaceutical
SeedJun 21, 2023
Amount Raised: $6,002,574
Concr

London, England, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

BiopharmaBiotechnologyMachine Learning
SeedMay 5, 2023
Amount Raised: $910,008
Genialis

Boston, Massachusetts, United States

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform.

BioinformaticsBiotechnologyHealth CareMedicalPrecision Medicine
Series AMar 29, 2023
Amount Raised: $13,000,000
Iktos

Paris, Ile-de-France, France

Iktos is a deep learning technology platform focused on new drug design and discovery.

Artificial Intelligence (AI)BiotechnologyChemicalHealth CarePharmaceutical
Series AMar 9, 2023
Amount Raised: $16,408,385
Yonalink

Jerusalem, Yerushalayim, Israel

Yonalink is a SaaS solution providing EHR-to-EDC streaming to improve clinical trial operations by reducing human error and staff burnout.

Clinical TrialsHealth CareMedical
SeedNov 9, 2022
Amount Raised: $6,000,000
Mika

Berlin, Berlin, Germany

Mika is a digital platform empowering people affected by cancer.

Health CaremHealthTherapeutics
Series AMay 9, 2022
Amount Raised: $10,563,321